Get Your Health Score
Can These Two Compounds Really Protect Your Eyes? Here's What the Research Shows About Lutein and Zeaxanthin
Published on: May 11, 2026

You may have heard that eating spinach is good for your eyesight. That’s because it contain powerful antioxidants called lutein and zeaxanthin.1 These aren't exotic supplements manufactured in a laboratory; they're natural yellow pigments found in leafy greens, corn, and eggs that your eyes actively accumulate.1 The question isn't whether they're important for eye health; they clearly are. The question is whether eating more of them (or taking supplements) actually prevents blindness and keeps your vision sharp.

The answer is more nuanced than supplement manufacturers suggest, but also more encouraging than most people realise. Modern research gives us clear evidence about what works, when it matters most, and how much you actually need.

Why Your Eyes Have Become a Hot Topic in Nutrition Science

Let's start with why this matters at all. If you live long enough, you'll likely face one of three common eye problems. Age-related macular degeneration (AMD) affects 1 in 8 American adults over 40; that's roughly 18 million people.2 Cataracts are even more common, affecting up to half of people over 60.3 And in our screen-heavy era, dry eye syndrome hits 1 in 5 adults over 40, leaving eyes uncomfortable and vision temporarily blurred.4

These aren't minor inconveniences. AMD is the leading cause of irreversible vision loss in older adults in developed countries.5 Cataracts eventually become so opaque that you can't read, drive, or recognise faces without surgery.6 Dry eye can make working at a computer genuinely painful.7

What makes this relevant to lutein and zeaxanthin is that all three conditions involve oxidative stress and inflammation in the eye, a combination that these two compounds directly address.1 For the first time, we have tools to measure whether they're actually working.

What Are Lutein and Zeaxanthin?

Think of them as nature's built-in sunglasses.8 Both are carotenoids (the same class of compounds that make carrots orange and tomatoes red). But lutein and zeaxanthin are something special: unlike most carotenoids, your body can transport them through your bloodstream directly into your eye, where they accumulate in the macula, the tiny central region of your retina responsible for sharp, detailed vision.8

The macula is only about the size of a pinhead, but it handles most of your visual perception.9 It's also relentlessly exposed to bright light, which generates harmful free radicals within the cells.10 This is where lutein and zeaxanthin act as a protective barrier.8

They work through multiple overlapping mechanisms. First, they filter out blue light (the high-energy wavelengths that trigger the most damaging free-radical reactions).8 Second, they directly neutralise free radicals that do get through, preventing them from damaging cell membranes and DNA.11 Third, they activate your cells' own antioxidant defences, triggering the production of protective enzymes such as glutathione peroxidase and superoxide dismutase.12 Fourth, they reduce inflammation by suppressing inflammatory pathways that accelerate cellular ageing.11

This isn't theoretical. Scientists can measure the thickness of lutein and zeaxanthin in your macula using a technique called heterochromatic flicker photometry.13 Higher measurements (called macular pigment optical density, or MPOD) correlate with better protection and improved visual function. And importantly, these measurements can increase when you consume more of these compounds.

AMD: Where the Evidence is Clearest

Let's focus on AMD first, as this is where we have the most substantial research. The landmark study is AREDS2 (Age-Related Eye Disease Study 2), a large clinical trial involving thousands of participants with existing AMD, followed for 5 years, then for an additional 10 years.14

The primary finding was somewhat disappointing: adding lutein and zeaxanthin to the standard AREDS supplement didn't significantly reduce progression to advanced AMD in the general study population. About 31% of people taking a placebo progressed to advanced AMD over 5 years; about 29% of those taking lutein and zeaxanthin did. The 2-percentage-point difference wasn't statistically meaningful.14

However, secondary analyses revealed a more complete picture. In people who had low dietary intake of lutein and zeaxanthin at the start of the study, supplementation reduced their risk of developing advanced AMD by 26%.15 Moreover, for people with large drusen (an early warning sign of AMD), the benefit was even greater: lutein and zeaxanthin reduced the risk of progression to advanced wet AMD by 35%.15

The long-term data adds another dimension. After 10 years of follow-up, the hazard ratio for progression with lutein and zeaxanthin was 0.91, suggesting a 9% relative reduction in progression rates (a modest but consistent benefit sustained over a decade).16

Large population studies show even stronger effects with dietary intake. When researchers compared people with the highest dietary consumption of lutein and zeaxanthin to those with the lowest, they found a 40% risk reduction for advanced AMD; essentially, this cuts the risk in half.17

What does this mean in practical terms? If you have early AMD and poor dietary intake, supplementation with lutein and zeaxanthin can slow vision loss. The protection is real but modest, not dramatic. The stronger message is: if you maintain a healthy diet throughout your life, your risk of AMD is substantially lower.

The MPOD Measurement: Proof That Something Is Happening

One of the clearest pieces of evidence comes from measuring what's actually happening in your eye. When people supplement with lutein, their macular pigment optical density increases measurably. A 20 mg daily dose increased MPOD by about 0.076 units over 48 weeks; a combination of lutein and zeaxanthin increased it by about 0.058 units. These gains appeared within 8 to 16 weeks for most people.18

More importantly, these increases correlate with measurable improvements in vision. People with higher MPOD show:18,19

  • Better recovery after glare (eyes adjust faster after bright lights)
  • Improved contrast sensitivity (easier to see objects against backgrounds)
  • Better visual acuity (slightly sharper vision)
  • Reduced problems with glare disability

This isn't a cure, but it's an actual improvement in visual function. For someone worried about AMD progression, measurable increases in eye protection are meaningful.

AMD prevalence climbs with age Figure 1: Age-related macular degeneration becomes increasingly common after age 65, affecting approximately 3 in 10 people by age 80. Data from the CDC Vision Health Surveillance System and PubMed epidemiologic studies.20,21,22

Cataracts: Where Diet Matters More Than Supplements

The story for cataracts is different and somewhat more encouraging when it comes to dietary approaches. The AREDS2 cataract data (part of the same large trial) showed that supplementation had no overall effect on cataract surgery rates in the general population. However, in the subgroup with the lowest baseline dietary intake, supplements reduced the need for cataract surgery by 32%.25

What's more interesting is what population-based studies show. Women with high dietary intakes of lutein and zeaxanthin had 23% lower prevalence of nuclear cataracts, the most common type.23 This is one of the few dietary factors shown to protect against cataracts, which typically develop with age.

The practical message: regular consumption of lutein and zeaxanthin-rich foods appears to slow cataract development over a lifetime.23 Supplements seem less effective for prevention, probably because they enter the body more abruptly than dietary sources, which provide sustained, long-term protection.25

Dry Eye: The Most Impressive Recent Evidence

Here's where the newest research gets exciting. Until very recently, we had limited evidence for lutein and zeaxanthin in dry eye syndrome. But 2024 and 2025 have brought multiple randomised controlled trials with surprisingly strong results.

A recent double-blind trial examined lutein and zeaxanthin supplementation (often combined with other compounds, such as elderberries) in people with moderate-to-severe dry eye. The results were striking:24

  • Symptom severity improved by 52% (measured on a standardised scale, symptoms dropped from 38.15 to 18.26, essentially cutting severity roughly in half)
  • Tear production improved on the Schirmer test
  • Tear film stability improved, meaning tears stayed on the eye longer without breaking apart
  • Subjective improvement on a visual analogue scale showed 26.7% symptom reduction

This is one of the most impressive improvements documented for any eye supplement. The mechanism makes sense: the anti-inflammatory and antioxidant effects of lutein and zeaxanthin protect the tear-producing glands and the surface epithelium, addressing root causes rather than just lubricating the eye.26

Risk reduction across multiple eye conditions Figure 2: Lutein and zeaxanthin provide different levels of protection depending on the condition. Data from meta-analyses, AREDS2 trials, and recent 2024-2025 randomised controlled trials.15,17,23,24

For the millions of people struggling with dry eye (especially those working long hours on screens), this is meaningful evidence. Unlike AMD prevention (which remains uncertain for healthy eyes), dry eye treatment with lutein and zeaxanthin shows promise.

Other Conditions: Where Research is Still Emerging

For diabetic retinopathy, glaucoma, and myopia, the evidence is more preliminary. In diabetic patients, researchers have found that serum lutein and zeaxanthin levels are significantly lower than in non-diabetic individuals, and animal studies have shown protective effects. Early human studies suggest that supplementation may improve visual acuity and contrast sensitivity, but large clinical trials are still needed.27,28,29

For glaucoma, macular pigment can be augmented with supplementation, and greater dietary carotenoid intake shows a protective trend. The proposed mechanism is neuroprotection of the optic nerve, but more research is needed.30,31

In myopia, including high myopia, lutein and zeaxanthin supplementation appears to help preserve macular function in eyes at higher risk for macular degeneration, but this remains an emerging area of research.32,33,34

Where to Get These Compounds: Food vs. Supplements

The Food-First Approach

The most practical step is to first try to meet your lutein and zeaxanthin needs through food. Not only is this more effective based on long-term epidemiologic evidence, but it's also more practical and enjoyable.

The richest sources are:35,36,37

  • Kale: 11.4 mg lutein per 100 grams. A single cup of raw kale provides 3.4 mg, more than one-third of your daily goal. Cooked kale is even denser
  • Spinach: 7.9 mg lutein per 100 grams. A cup of raw spinach provides 2.4 mg.
  • Broccoli: About 3.3 mg per 100 grams
  • Corn: The richest source of zeaxanthin, the partner compound for macula health
  • Eggs: One large egg yolk contains meaningful amounts of both lutein and zeaxanthin, and the natural fat in the yolk enhances absorption. Research shows that eating one egg daily for five weeks increased serum lutein by 26% and zeaxanthin by 38%
  • Other sources Include Peas, Brussels sprouts, asparagus, orange peppers, kiwis, grapes, and cantaloupe.

Lutein content in common foods Figure 3: Common foods ranked by lutein content per serving. The recommended daily goal of 10 mg lutein plus 2 mg zeaxanthin is achievable through ordinary food choices. Data from food composition databases and PubMed research.35,36,37

The Absorption Secret: Why Fat Matters Enormously

Here's the critical detail most people miss: lutein and zeaxanthin are fat-soluble compounds.38 Your intestine can only absorb them if dietary fat is present to form the micelles that carry them across the intestinal wall.39

The difference is dramatic. A high-fat meal increased plasma lutein levels by 207%. The same meal with low-fat ingredients increased levels by 88% (less than half). In other words, eating your greens with olive oil dressing, butter, avocado, or nuts more than doubles absorption compared to eating them plain or with minimal fat.40

Olive oil appears particularly beneficial. Studies show it delivers 37 to 41% higher plasma lutein and zeaxanthin levels than sunflower oil, and 23 to 31% greater accumulation in eye tissue.41

The practical implication: a spinach salad with olive oil and walnuts beats a spinach salad with vinegar and no fat. Eggs with greens beat greens alone. Kale cooked in butter beats raw kale.

The American Intake Gap

Despite the widespread availability of these foods, most Americans are profoundly deficient. The average American consumes only 1 to 2 mg of lutein daily, roughly 80 to 90% below the recommended 10 mg lutein plus 2 mg zeaxanthin daily (the AREDS2 gold standard).8,15

This gap is entirely fixable through food:

  • Two cups of raw spinach (0.5 mg), half a cup of cooked kale (4 mg), one egg (0.5 mg), and half a cup of corn (0.5 mg) approximately meet the daily goal
  • Or simply incorporating leafy greens into lunch and dinner, plus eggs several times weekly, plus regular corn consumption, gets most people there

Fresh, frozen, and lightly cooked vegetables all retain lutein and zeaxanthin equally well, so storage methods and cooking styles don't meaningfully reduce these compounds.

When Supplementation Makes Sense

Supplementation becomes evidence-based for specific populations:

  1. People with diagnosed AMD (especially intermediate AMD): AREDS2 showed a clear benefit in slowing progression
  2. Adults over 60 with very low dietary intake of greens: If you genuinely cannot or will not eat adequate vegetables
  3. Those with a strong family history of AMD plus a poor diet: Risk-stratified decision-making with an eye care provider
  4. People with digestive conditions affecting fat absorption: Where dietary sources may be insufficiently absorbed

For healthy people without AMD or a strong family history, the evidence for supplementation to prevent disease is currently unproven. This doesn't mean it's unhelpful; general antioxidant protection probably has value, but it's not yet proven to prevent AMD or other eye diseases in healthy eyes.

The standard AREDS2 supplement dose is 10 mg lutein plus 2 mg zeaxanthin daily.15 Clinical trials have safely tested up to 20 mg lutein daily, and safety data extend to 10+ years of continuous use with no serious adverse effects.42

Important note on formulation: newer micromicelle- and MCT oil-based formulations show a greater increase in bioavailability than basic formulations.43,44 If you do supplement, the choice of product matters.

Individual Response Varies: And That's Okay

One complication that research has uncovered is individual variation in response. Most people show measurable increases in macular pigment when supplemented with lutein and zeaxanthin. A minority of people show little to no increase, despite higher serum levels of the compounds.45,46

This genetic variation is frustrating but unsurprising in medicine. What's important to know is that people with low baseline macular pigment tend to show the most dramatic responses to supplementation.30,47 Low MPOD has been shown to be a potential marker of higher AMD risk.48 If you have been diagnosed with low MPOD, supplementation may be particularly worthwhile for you.

You cannot predict your individual response in advance, but if you supplement and have your MPOD measured after three to four months, you'll know whether you're a responder.

Timeline of macular pigment improvement Figure 4: Macular pigment optical density (MPOD) builds gradually over 48 weeks with supplementation. The 20 mg lutein dose and the combination approach show different trajectories, with most improvement visible by 12-16 weeks. Data from 48-week randomised controlled trials.18

Safety: The Good News

One thing you never need to worry about with lutein and zeaxanthin is serious toxicity. AREDS2 studied 5,000+ people over 5 years and then 10 years, looking for any adverse effects. The results: no serious adverse events; no changes in liver or kidney function; no increased cancer risk (notably, no increase in lung cancer, unlike with beta-carotene supplements in smokers).1,16,49

Animal toxicity studies have tested doses up to 1000 mg per kilogram of body weight per day with no adverse effects. To put that in perspective, a 70 kg person would need to consume 70,000 mg (70,000,000 micrograms) per day to approach the no-effect level observed in animal studies. The standard AREDS2 dose of 12 mg is 5,800 times lower than that threshold.50,51

The most common side effect is carotenemia (yellowing of the skin), which occurs only at extremely high doses and is completely harmless and reversible.52,53

The Bottom Line: What You Should Actually Do

If you have early or intermediate AMD: Discuss AREDS2-type supplementation with your eye care provider. The evidence shows a clear benefit for slowing progression, especially if your dietary intake has been low. Supplements are safe and affordable.

If you're over 60 without AMD but with risk factors, focus first on dietary sources: make leafy greens, corn, and eggs regular parts of your diet, always with healthy fats. This approach has stronger long-term evidence and is more sustainable.

If you have dry eye syndrome, Supplementation shows promising evidence for symptom relief. Discuss with your eye care provider whether a lutein and zeaxanthin supplement makes sense for you.

If you're younger and healthy: Ensure your diet includes reasonable amounts of these compounds. You don't need supplements to prevent AMD (as their benefits are unproven in healthy eyes), but dietary intake almost certainly helps. It's also likely beneficial for overall antioxidant protection and brain health.

For everyone: The practical recommendation is straightforward. Include:

  • 2-3 servings of dark leafy greens weekly (raw in salads or cooked in meals)
  • Corn products 2-3 times weekly
  • Eggs 3-7 times weekly (you don't need to restrict egg consumption for heart health; the evidence no longer supports this)
  • Always pair these foods with healthy fats (olive oil, avocado, nuts, seeds, or butter)

This combination addresses the 80-90% intake gap most Americans face and provides proven protection. Benefits develop slowly over years and decades, not weeks, but evidence shows that maintaining this approach throughout life substantially reduces your risk of AMD and cataracts.

Helpful Resources

Age-Related Macular Degeneration (AMD)

Cataracts

Dry Eye Syndrome

Lutein and Zeaxanthin Research

Dietary Sources and Nutrition

Clinical Trial Data

References/Helpful References

  1. Lopresti AL, Smith SJ. The effects of lutein/ zeaxanthin (Lute-gen®) on eye health, eye strain, sleep quality, and attention in high electronic screen users: a randomized, double-blind, placebo-controlled study. Frontiers in Nutrition [Internet]. 2025 Feb 3 [cited 2026 May 7];12. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC11830589/
  2. Chaudhuri M, Hassan Y, Prardhana P, Muktha S Bellary Pattanashetty, Abdin ZU, Siddiqui HF. Age-Related Macular Degeneration: An Exponentially Emerging Imminent Threat of Visual Impairment and Irreversible Blindness. Cureus [Internet]. 2023 May 29 [cited 2026 May 7];15(5). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300666/
  3. Xiang Y, Jiang H, Zhao L, Liu Q, Lin H. Delays in Seeking Medical Services in Elderly Patients With Senile Cataract. Frontiers in Psychology [Internet]. 2022 Jul 12 [cited 2026 May 7];13. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314650/pdf/fpsyg-13-930726.pdf
  4. Findlay Q, Reid K. Dry eye disease: when to treat and when to refer. Australian Prescriber [Internet]. 2018 Oct 2 [cited 2026 May 7];41(5):160–3. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202299/
  5. Vyawahare H, Shinde P. Age-Related Macular Degeneration: Epidemiology, Pathophysiology, Diagnosis, and Treatment. Cureus [Internet]. 2022 Sep 26 [cited 2026 May 7];14(9). Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC9595233/
  6. Nizami AA, Gulani AC. Cataract [Internet]. Nih.gov. StatPearls Publishing; 2024 [cited 2026 May 7]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK539699/
  7. Kaur K, Gurnani B, Nayak S, Deori N, Kaur S, Jethani J, et al. Digital Eye Strain- A Comprehensive Review. Ophthalmology and Therapy [Internet]. 2022 Jul 9 [cited 2026 May 7];11(5):1655–80. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434525/
  8. Mrowicka M, Mrowicki J, Kucharska E, Majsterek I. Lutein and Zeaxanthin and Their Roles in Age-Related Macular Degeneration—Neurodegenerative Disease. Nutrients [Internet]. 2022 Feb 16 [cited 2026 May 7];14(4):827. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC8874683/
  9. Seher Koksaldi, Mustafa Kayabasi, Karti O, Saatci AO. Clinical anatomy of the macula. Medical Hypothesis Discovery & Innovation in Ophthalmology [Internet]. 2025 Jul 31 [cited 2026 May 7];14(2):17–27. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC12330045/
  10. Yara Abukhaled. Reactive oxygen species and oxidative stress in ocular disease: from molecular mechanisms to targeted therapies. Medical Hypothesis Discovery & Innovation in Ophthalmology [Internet]. 2025 Sep 27 [cited 2026 May 7];14(3):136–45. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC12528760/
  11. Stringham NT, Green M, Roche W, Prado-Cabrero A, Mulcahy R, Nolan J. Lutein, zeaxanthin, and meso-zeaxanthin supplementation attenuates inflammatory cytokines and markers of oxidative cardiovascular processes in humans. Nutrition Metabolism and Cardiovascular Diseases [Internet]. 2024 May 1 [cited 2026 May 7];34(8). Available from: https://www.nmcd-journal.com/article/S0939-4753(24)00177-7/fulltext
  12. Ahn YJ, Kim H. Lutein as a Modulator of Oxidative Stress-Mediated Inflammatory Diseases. Antioxidants [Internet]. 2021 Sep 13 [cited 2026 May 7];10(9):1448. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC8470349/
  13. Davey PG, Rosen RB, Gierhart DL. Macular Pigment Reflectometry: Developing Clinical Protocols, Comparison with Heterochromatic Flicker Photometry and Individual Carotenoid Levels. Nutrients [Internet]. 2021 Jul 26 [cited 2026 May 7];13(8):2553. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC8399813/
  14. The Age-Related Eye Disease Study 2 (AREDS2) Research Group. Lutein + Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration. JAMA [Internet]. 2013 May 15 [cited 2026 May 7];309(19):2005. Available from: https://jamanetwork.com/journals/jama/fullarticle/1684847
  15. Chew EY, Clemons TE, SanGiovanni JP, Danis RP, Ferris FL, Elman MJ, et al. Secondary Analyses of the Effects of Lutein/Zeaxanthin on Age-Related Macular Degeneration Progression. JAMA Ophthalmology [Internet]. 2014 Feb 1 [cited 2026 May 7];132(2):142. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC4636082/
  16. Chew EY, Clemons TE, Agrón E, Domalpally A, Keenan TDL, Vitale S, et al. Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression. JAMA Ophthalmology [Internet]. 2022 Jun 2 [cited 2026 May 7];140(7). Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC9164119/
  17. Wu J, Cho E, Willett WC, Sastry SM, Schaumberg DA. Intakes of Lutein, Zeaxanthin, and Other Carotenoids and Age-Related Macular Degeneration During 2 Decades of Prospective Follow-up. JAMA Ophthalmology [Internet]. 2015 Dec 1 [cited 2026 May 7];133(12):1415. Available from: https://jamanetwork.com/journals/jamaophthalmology/fullarticle/2448581
  18. Ma L, Yan SF, Huang YM, Lu XR, Qian F, Pang HL, et al. Effect of Lutein and Zeaxanthin on Macular Pigment and Visual Function in Patients with Early Age-related Macular Degeneration. Ophthalmology [Internet]. 2012 Nov [cited 2026 May 7];119(11):2290–7. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0161642012005453
  19. Stringham JM, Garcia PV, Smith PA, McLin LN, Foutch BK. Macular Pigment and Visual Performance in Glare: Benefits for Photostress Recovery, Disability Glare, and Visual Discomfort. Investigative Opthalmology & Visual Science [Internet]. 2011 Sep 22 [cited 2026 May 7];52(10):7406. Available from: https://iovs.arvojournals.org/article.aspx?articleid=2165615
  20. CDC. Prevalence Estimate for Age-Related Macular Degeneration (AMD) [Internet]. Vision and Eye Health Surveillance System. 2024 [cited 2026 May 7]. Available from: https://www.cdc.gov/vision-health-data/prevalence-estimates/amd-prevalence.html
  21. Rein DB, Wittenborn JS, Burke-Conte Z, Gulia R, Robalik T, Ehrlich JR, et al. Prevalence of Age-Related Macular Degeneration in the US in 2019. JAMA Ophthalmology [Internet]. 2022 Nov 3 [cited 2026 May 7];140(12). Available from: https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2797921
  22. Singh RB, Stettler I, Romano F, Parmar UPS, Surico PL, Ding X, et al. Prevalence of Age-Related Macular Degeneration in the United States: A Medicare-Based Analysis from 2014 to 2021. Ophthalmic research [Internet]. 2025 [cited 2026 May 7];68(1):573–82. Available from: https://pubmed.ncbi.nlm.nih.gov/41194565/
  23. Moeller SM, Voland R, Tinker L, Blodi BA, Klein ML, Gehrs KM, et al. Associations between age-related nuclear cataract and lutein and zeaxanthin in the diet and serum in the Carotenoids in the Age-Related Eye Disease Study, an Ancillary Study of the Women’s Health Initiative. Archives of ophthalmology (Chicago, Ill : 1960) [Internet]. 2008 Mar 1 [cited 2026 May 7];126(3):354–64. Available from: https://www.ncbi.nlm.nih.gov/pubmed/18332316
  24. Goh KM, Sin E, Lim Y, Tan PY, Biswas S, Lew LA, et al. Effect of Dietary Supplementation with Lutein, Zeaxanthin, and Elderberries on Dry Eye Disease (DED) and Immunity: A Randomized Controlled Trial. Nutrients [Internet]. 2024 Dec 18 [cited 2026 May 7];16(24):4366–6. Available from: https://www.mdpi.com/2072-6643/16/24/4366
  25. Chew EY. Lutein/Zeaxanthin for the Treatment of Age-Related Cataract. JAMA Ophthalmology [Internet]. 2013 Jul 1 [cited 2026 May 7];131(7):843. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC6774801
  26. Huang SC, Lei YP, Hsiao MC, Hsieh YK, Tang QP, Chen C, et al. Multicomponent Dietary Supplementation: Impact on Tear Secretion and Ocular Surface Inflammation in Dry Eye Syndrome Patients. Antioxidants [Internet]. 2025 Jan 16 [cited 2026 May 7];14(1):103–3. Available from: https://www.mdpi.com/2076-3921/14/1/103
  27. Garcia-Medina JJ, Rubio-Velazquez E, Foulquie-Moreno E, Casaroli-Marano RP, Pinazo-Duran MD, Zanon-Moreno V, et al. Update on the Effects of Antioxidants on Diabetic Retinopathy: In Vitro Experiments, Animal Studies and Clinical Trials. Antioxidants [Internet]. 2020 Jun 26 [cited 2026 May 7];9(6):561. Available from: https://www.mdpi.com/2076-3921/9/6/561
  28. Wang W, Ka Cheung Tam, Tsz Chung Ng, Rajesh Kumar Goit, Lok K, Cheuk A. Long-term lutein administration attenuates retinal inflammation and functional deficits in early diabetic retinopathy in Ins2Akita/+ mice. BMJ open diabetes research & care [Internet]. 2020 Jul 1 [cited 2026 May 7];8(1):e001519–9. Available from: https://drc.bmj.com/content/8/1/e001519
  29. Zhang PC, Wu CR, Wang ZL, Wang LY, Han Y, Sun SL, et al. Effect of lutein supplementation on visual function in nonproliferative diabetic retinopathy. Asia Pacific Journal of Clinical Nutrition [Internet]. 2017 May 1 [cited 2026 May 7];26(3):406–11. Available from: https://pubmed.ncbi.nlm.nih.gov/28429904/
  30. Loughman J, Loskutova E, Butler JS, Siah WF, O’Brien C. Macular Pigment Response to Lutein, Zeaxanthin, and Meso-zeaxanthin Supplementation in Open-Angle Glaucoma. Ophthalmology Science [Internet]. 2021 Sep [cited 2026 May 7];1(3):100039. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC9562333/
  31. Lem DW, Gierhart DL, Davey PG. Carotenoids in the Management of Glaucoma: A Systematic Review of the Evidence. Nutrients [Internet]. 2021 Jun 6 [cited 2026 May 7];13(6):1949. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC8228567
  32. Zhang Y, Hao J, Cao K, Qi Y, Wang N, Han S. Macular pigment optical density responses to different levels of zeaxanthin in patients with high myopia. Graefes Archive for Clinical and Experimental Ophthalmology [Internet]. 2022 Jan 19 [cited 2026 May 7];260(7):2329–37. Available from: https://pubmed.ncbi.nlm.nih.gov/35044504/
  33. Yoshida T, Takagi Y, Tae Igarashi-Yokoi, Ohno-Matsui K. Efficacy of lutein supplements on macular pigment optical density in highly myopic individuals: A randomized controlled trial. Medicine (Baltimore) [Internet]. 2023 Mar 24 [cited 2026 May 7];102(12):e33280–0. Available from: https://pubmed.ncbi.nlm.nih.gov/36961139/
  34. National Academies of Sciences, Engineering, and Medicine, Division of Behavioral and Social Sciences and Education, Board on Behavioral, Cognitive, and Sensory Sciences, Committee on Focus on Myopia: Pathogenesis and Rising Incidence. Washington (DC). Current and Emerging Treatment Options for Myopia [Internet]. Nih.gov. National Academies Press (US); 2024 [cited 2026 May 7]. Available from: https://www.ncbi.nlm.nih.gov/sites/books/NBK607613
  35. USDA. Description Measure Lutein + zeaxanthin(µg)Per Measure [Internet]. 2018 [cited 2026 May 7]. Available from: https://www.nal.usda.gov/sites/default/files/page-files/Lutein_zeaxanthin.pdf
  36. Goodrow EF, Wilson TA, Houde SC, Vishwanathan R, Scollin PA, Handelman G, et al. Consumption of One Egg Per Day Increases Serum Lutein and Zeaxanthin Concentrations in Older Adults without Altering Serum Lipid and Lipoprotein Cholesterol Concentrations. The Journal of Nutrition [Internet]. 2006 Oct 1 [cited 2026 May 7];136(10):2519–24. Available from: https://www.sciencedirect.com/science/article/pii/S0022316622084723
  37. Abdel-Aal ES, Akhtar H, Zaheer K, Ali R. Dietary Sources of Lutein and Zeaxanthin Carotenoids and Their Role in Eye Health. Nutrients [Internet]. 2013 Apr 9 [cited 2026 May 7];5(4):1169–85. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705341/
  38. Eisenhauer B, Natoli S, Liew G, Flood V. Lutein and Zeaxanthin—Food Sources, Bioavailability and Dietary Variety in Age‐Related Macular Degeneration Protection. Nutrients [Internet]. 2017 Feb 9 [cited 2026 May 7];9(2):120. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331551/pdf/nutrients-09-00120.pdf
  39. Iqbal J, Hussain MM. Intestinal lipid absorption. American Journal of Physiology-Endocrinology and Metabolism [Internet]. 2009 Jun [cited 2026 May 7];296(6):E1183–94. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC2692399/
  40. Roodenburg AJ, Leenen R, van het Hof KH, Weststrate JA, Tijburg LB. Amount of fat in the diet affects bioavailability of lutein esters but not of α-carotene, β-carotene, and vitamin E in humans. The American Journal of Clinical Nutrition [Internet]. 2000 May 1 [cited 2026 May 7];71(5):1187–93. Available from: https://www.sciencedirect.com/science/article/pii/S0002916523071435
  41. Lakshminarayana R, Raju M, Krishnakantha TP, Baskaran V. Lutein and Zeaxanthin in Leafy Greens and Their Bioavailability:  Olive Oil Influences the Absorption of Dietary Lutein and Its Accumulation in Adult Rats. Journal of Agricultural and Food Chemistry [Internet]. 2007 Jun 30 [cited 2026 May 7];55(15):6395–400. Available from: https://pubmed.ncbi.nlm.nih.gov/17602649/
  42. Ranard KM, Jeon S, Mohn ES, Griffiths JC, Johnson EJ, Erdman JW. Dietary guidance for lutein: consideration for intake recommendations is scientifically supported. European Journal of Nutrition [Internet]. 2017 Nov 17 [cited 2026 May 7];56(S3):37–42. Available from: https://link.springer.com/article/10.1007/s00394-017-1580-2
  43. Green-Gomez M, Prado-Cabrero A, Moran R, Power T, Gómez-Mascaraque LG, Stack J, et al. The Impact of Formulation on Lutein, Zeaxanthin, and meso-Zeaxanthin Bioavailability: A Randomised Double-Blind Placebo-Controlled Study. Antioxidants [Internet]. 2020 Aug 18 [cited 2026 May 7];9(8):767. Available from: https://www.mdpi.com/2076-3921/9/8/767
  44. Mehkri S, Dinesh KG, Ashok G, Bopanna K. Comparative Pharmacokinetics of Lutein and Zeaxanthin from Phospholipid, Liposomal, and MCT Formulations in SD Rats. Pharmaceutics [Internet]. 2025 Dec 2 [cited 2026 May 7];17(12):1552. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC12736751/
  45. Obana A, Tanito M, Gohto Y, Okazaki S, Gellermann W, Bernstein PS. Changes in Macular Pigment Optical Density and Serum Lutein Concentration in Japanese Subjects Taking Two Different Lutein Supplements. Virgili G, editor. PLOS ONE [Internet]. 2015 Oct 9 [cited 2026 May 7];10(10):e0139257. Available from: https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0139257
  46. Thurnham DI. Macular zeaxanthins and lutein – a review of dietary sources and bioavailability and some relationships with macular pigment optical density and age-related macular disease. Nutrition Research Reviews [Internet]. 2007 Dec [cited 2026 May 7];20(2):163–79. Available from: https://www.cambridge.org/core/services/aop-cambridge-core/content/view/6E38297230327FE8108E398DD8570EF0/S0954422407842235a.pdf/macular_zeaxanthins_and_lutein_a_review_of_dietary_sources_and_bioavailability_and_some_relationships_with_macular_pigment_optical_density_and_agerelated_macular_disease.pdf
  47. Weigert G, Kaya S, Pemp B, Sacu S, Lasta M, Werkmeister RM, et al. Effects of Lutein Supplementation on Macular Pigment Optical Density and Visual Acuity in Patients with Age-Related Macular Degeneration. Investigative Opthalmology & Visual Science [Internet]. 2011 Oct 17 [cited 2026 May 7];52(11):8174. Available from: https://iovs.arvojournals.org/article.aspx?articleid=2186933
  48. Bone RA, Landrum JT, Guerra LH, Ruiz CA. Lutein and Zeaxanthin Dietary Supplements Raise Macular Pigment Density and Serum Concentrations of these Carotenoids in Humans. The Journal of Nutrition [Internet]. 2003 Apr 1 [cited 2026 May 7];133(4):992–8. Available from: https://www.sciencedirect.com/science/article/pii/S0022316622157159
  49. Chew EY, Clemons T, SanGiovanni JP, Danis R, Domalpally A, McBee W, et al. The Age-related Eye Disease Study 2 (AREDS2). Ophthalmology [Internet]. 2012 Nov [cited 2026 May 7];119(11):2282–9. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3485447/
  50. Aguilar F, Dusemund B, Galtier P, Gilbert J, Gott DM, Grilli S, et al. Scientific Opinion on the re-evaluation of lutein preparations other than lutein with high concentrations of total saponified carotenoids at levels of at least 80%. EFSA Journal [Internet]. 2011 May [cited 2026 May 7];9(5):2144. Available from: https://efsa.onlinelibrary.wiley.com/doi/10.2903/j.efsa.2011.2144
  51. Edwards JA. Zeaxanthin: Review of Toxicological Data and Acceptable Daily Intake. Journal of Ophthalmology [Internet]. 2016 [cited 2026 May 7];2016:1–15. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC4738691
  52. Nasser YA, Jamal Z, Albugeaey M. Carotenemia [Internet]. Nih.gov. StatPearls Publishing; 2023 [cited 2026 May 7]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK534878
  53. EFSA Panel on Contaminants in the Food Chain (CONTAM). Scientific Opinion on the abiotic risks for public and animal health of glycerine as co‐product from the biodiesel production from Category 1 animal by‐products (ABP) and vegetable oils. EFSA Journal [Internet]. 2010 Dec [cited 2026 May 7];8(12). Available from: https://efsa.onlinelibrary.wiley.com/doi/10.2903/j.efsa.2010.1934
Share

Health Library Team

Klarity is a citizen-centric digital health platform and content hub that empowers people to proactively manage their wellbeing with accurate, actionable insights and tools. Through advanced data analysis, AI-led risk prediction, and personalised recommendations, Klarity helps users detect and reduce their risk of chronic conditions and maintain a healthier lifestyle. The My Klarity Health Library extends this mission with accessible, expert-informed articles on prevention, nutrition, chronic disease, sexual health, skincare, sleep, and more, inspiring individuals to make informed changes in their daily lives.

arrow-right